danegaptide: Clinical Trials

1 trial of danegaptide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow danegaptide: new trials by email Literature Review of danegaptide trials Research Report on danegaptide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction
danegaptide, Placebo - Focus of Study is STEMI
Phase 2CompletedZealand Pharma5912013-11-012018-04-06

Sponsors

Zealand Pharma (1)

Countries

Denmark (1)

Top investigators

Thomas Engstrom, MD, DMSci (1)

Results publications

PMID 29602883, PMID 36576342